Currently, Aehr Test Systems [AEHR] is trading at $28.51, down -0.94%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AEHR shares have gain 6.26% over the last week, with a monthly amount glided 55.71%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Aehr Test Systems [NASDAQ: AEHR] stock has seen the most recent analyst activity on July 17, 2024, when Craig Hallum upgraded its rating to a Buy and also boosted its price target to $25 from $12. Previously, Craig Hallum downgraded its rating to Hold on March 26, 2024, and kept the price target unchanged to $12. On March 25, 2024, downgrade downgraded it’s rating to Mkt Perform. William Blair started tracking the stock assigning a Outperform rating.
This stock has fluctuated between a low of $6.27 and a high of $28.80 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $25 within the next 12 months. Aehr Test Systems [NASDAQ: AEHR] shares were valued at $28.51 at the most recent close of the market. An investor can expect a potential drop of -12.31% based on the average AEHR price forecast.
Analyzing the AEHR fundamentals
Trailing Twelve Months sales for Aehr Test Systems [NASDAQ:AEHR] were 58.97M which represents -15.13% decline. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at -0.1%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.03, Equity is -0.03 and Total Capital is -0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Aehr Test Systems [NASDAQ:AEHR] is 5.68. Further, the Quick Ratio stands at 2.99, while the Cash Ratio is 1.57. Considering the valuation of this stock, the price to sales ratio is 14.46, the price to book ratio is 6.93.
Transactions by insiders
Recent insider trading involved SLAYEN HOWARD T, Director, that happened on Aug 15 ’25 when 10000.0 shares were purchased. Director, OLIPHANT LAURA completed a deal on Jul 25 ’25 to sell 5000.0 shares. Meanwhile, Director OLIPHANT LAURA bought 5000.0 shares on Jul 25 ’25.
